Glenview Trust’s iShares iBonds Dec 2030 Term Corporate ETF IBDV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11M Buy
506,320
+25,508
+5% +$556K 0.15% 112
2026
Q1
$10.5M Buy
480,812
+158,583
+49% +$3.5M 0.17% 114
2025
Q4
$7.11M Buy
322,229
+69,634
+28% +$1.54M 0.11% 131
2025
Q3
$5.59M Buy
252,595
+58,089
+30% +$1.28M 0.09% 145
2025
Q2
$4.28M Buy
194,506
+62,750
+48% +$1.36M 0.07% 162
2025
Q1
$2.86M Buy
131,756
+65,256
+98% +$1.4M 0.06% 184
2024
Q4
$1.42M Buy
66,500
+33,000
+99% +$714K 0.03% 240
2024
Q3
$743K Buy
33,500
+3,250
+11% +$70.9K 0.01% 299
2024
Q2
$643K Buy
+30,250
New +$639K 0.01% 308

Other funds holding IBDV

Glenview Trust's IBDV Position: Q2 2026 in Review

Glenview Trust increased its iShares iBonds Dec 2030 Term Corporate ETF (IBDV) stake by 5.3% in Q2 2026, buying an estimated $556K and bringing the position to 506,320 shares worth $11M. The position accounts for 0.15% of the portfolio, ranked #112.

Glenview Trust first reported a position in IBDV in Q2 2024 and has held it in 9 quarters since. 349 funds tracked by Wall St. Rank hold IBDV as of Q2 2026.

  • Glenview Trust held 506,320 shares of iShares iBonds Dec 2030 Term Corporate ETF worth $11M as of Q2 2026.
  • Glenview Trust bought 25,508 iShares iBonds Dec 2030 Term Corporate ETF shares in Q2 2026, an estimated $556K.
  • iShares iBonds Dec 2030 Term Corporate ETF made up 0.15% of Glenview Trust's portfolio in Q2 2026, its #112 holding.
  • Glenview Trust first reported a position in iShares iBonds Dec 2030 Term Corporate ETF in Q2 2024 and has held it in 9 quarters since.
  • 349 funds tracked by Wall St. Rank held iShares iBonds Dec 2030 Term Corporate ETF as of Q2 2026.

Based on Glenview Trust's 13F filing for Q2 2026, filed 11 Aug 2026.